STOLPER MARK bought TOI
July 7, 2026 · Form 4 insider transaction
STOLPER MARK bought 25,833 shares of Starling Oncology Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,833
Price
$0.00
Total value
N/A
InsiderSTOLPER MARK
Role—
CompanyStarling Oncology Inc (TOI)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 7, 2026
Filing dateJuly 9, 2026
Shares owned after25,833
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents RSU award that was fully vested upon grant.